Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GoodRx Holdings, Inc.GDRX · Entity 4838 | Chief Accounting Officer | March 08, 2026 | March 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GoodRx Holdings, Inc.
Report date March 08, 2026 · Filed March 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 183,061 |
Ending reported balance
After 2026-03-08 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-03-08 · Exercise / conversion · Acquired 10,201 · Balance 185,949 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 2 · 2026-03-08 · Tax withholding · Disposed 4,201 · Balance 181,748 Row 3 · 2026-03-08 · Exercise / conversion · Acquired 2,233 · Balance 183,981 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Row 4 · 2026-03-08 · Tax withholding · Disposed 920 · Balance 183,061 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 20,402 |
Reported balance
After 2026-03-08 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-03-08 · Exercise / conversion · Disposed 10,201 · Balance 20,402 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 17,858 |
Reported balance
After 2026-03-08 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-03-08 · Exercise / conversion · Disposed 2,233 · Balance 17,858 F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F3: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
F2: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
F3: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 12, 2024 Filed Mar 14, 2024 17:13 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantStock Option (Right to Buy) · Derivative | 51,462 | $0.00 Strike: $7.22 | $0.00 |
DisclosureSEC source: 0001809519-24-000050 · wk-form4_1710450803.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,462 Underlying: Class A Common Stock · 51,462 shares Expires 2034-03-12 F3 · derivative.exercise_date: The option will vest and become exercisable as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 17:13 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Unit · Derivative | 35,716 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000050 · wk-form4_1710450803.xml · derivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,716 Underlying: Class A Common Stock · 35,716 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award will vest as to 6.25% of the underlying shares on June 8, 2024 with the remaining 93.75% of the underlying shares to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 08, 2024 Filed Mar 8, 2024 17:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 10,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000045 · wk-form4_1709936137.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,008 Underlying: Class A Common Stock · 10,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 08, 2024 Filed Mar 8, 2024 17:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 3,745 | $7.54 | $28,237.30 |
DisclosureSEC source: 0001809519-24-000045 · wk-form4_1709936137.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,997 Read SEC document |
| March 08, 2024 Filed Mar 8, 2024 17:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000045 · wk-form4_1709936137.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| February 08, 2024 Filed Feb 8, 2024 16:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 12,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000013 · wk-form4_1707429280.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,615 Underlying: Class A Common Stock · 12,663 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| February 08, 2024 Filed Feb 8, 2024 16:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 5,190 | $6.22 | $32,281.80 |
DisclosureSEC source: 0001809519-24-000013 · wk-form4_1707429280.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,541 Read SEC document |
| February 08, 2024 Filed Feb 8, 2024 16:54 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,663 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000013 · wk-form4_1707429280.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| January 15, 2024 Filed Jan 16, 2024 17:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-24-000008 · wk-form4_1705442441.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,424 Underlying: Class A Common Stock · 2,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. Read SEC document |
| January 15, 2024 Filed Jan 16, 2024 17:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 1,068 | $6.64 | $7,091.52 |
DisclosureSEC source: 0001809519-24-000008 · wk-form4_1705442441.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,068 Read SEC document |
| January 15, 2024 Filed Jan 16, 2024 17:00 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-24-000008 · wk-form4_1705442441.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,136 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 17:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000059 · wk-form4_1702074000.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,209 Underlying: Class A Common Stock · 10,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 17:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 3,528 | $5.94 | $20,956.32 |
DisclosureSEC source: 0001809519-23-000059 · wk-form4_1702074000.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,530 Read SEC document |
| December 08, 2023 Filed Dec 8, 2023 17:20 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-23-000059 · wk-form4_1702074000.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,058 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| November 08, 2023 Filed Nov 8, 2023 16:45 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 12,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000028 · wk-form4_1699479901.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,278 Underlying: Class A Common Stock · 12,663 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| November 08, 2023 Filed Nov 8, 2023 16:45 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 4,379 | $5.40 | $23,646.60 |
DisclosureSEC source: 0001809519-23-000028 · wk-form4_1699479901.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,858 Read SEC document |
| November 08, 2023 Filed Nov 8, 2023 16:45 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,663 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-23-000028 · wk-form4_1699479901.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,237 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000011 · wk-form4_1697574384.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,030 Underlying: Class A Common Stock · 2,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 902 | $5.31 | $4,789.62 |
DisclosureSEC source: 0001809519-23-000011 · wk-form4_1697574384.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,574 Read SEC document |
| October 15, 2023 Filed Oct 17, 2023 16:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-23-000011 · wk-form4_1697574384.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 08, 2023 Filed Sep 8, 2023 17:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 10,201 | $0.00 | $0.00 |
DisclosureSEC source: 0001809519-23-000009 · wk-form4_1694208396.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 122,409 Underlying: Class A Common Stock · 10,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| September 08, 2023 Filed Sep 8, 2023 17:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 3,528 | $6.16 | $21,732.48 |
DisclosureSEC source: 0001809519-23-000009 · wk-form4_1694208396.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,870 Read SEC document |
| September 08, 2023 Filed Sep 8, 2023 17:26 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001809519-23-000009 · wk-form4_1694208396.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,398 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 16:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 12,662 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-041313 · ownership.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,941 Underlying: Class A Common Stock · 12,662 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 16:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 4,379 | $8.68 | $38,009.72 |
DisclosureSEC source: 0000950170-23-041313 · ownership.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,197 Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 16:08 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 12,662 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-041313 · ownership.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| July 15, 2023 Filed Jul 18, 2023 18:55 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,606 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-033431 · ownership.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,636 Underlying: Class A Common Stock · 2,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. Read SEC document |
| July 15, 2023 Filed Jul 18, 2023 18:55 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 902 | $7.46 | $6,728.92 |
DisclosureSEC source: 0000950170-23-033431 · ownership.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,914 Read SEC document |
| July 15, 2023 Filed Jul 18, 2023 18:55 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-033431 · ownership.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 21:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Units · Derivative | 10,201 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-027559 · ownership.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,610 Underlying: Class A Common Stock · 10,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 21:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 3,528 | $5.41 | $19,086.48 |
DisclosureSEC source: 0000950170-23-027559 · ownership.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,210 Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 21:30 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-027559 · ownership.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 18:02 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantStock option (Right to Buy) · Derivative | 276,900 | $0.00 Strike: $5.53 | $0.00 |
DisclosureSEC source: 0000950170-23-025772 · ownership.xml · derivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,900 Underlying: Class A Common Stock · 276,900 shares Expires 2033-05-30 F3 · derivative.exercise_date: The option will vest and become exercisable as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| May 30, 2023 Filed Jun 1, 2023 18:02 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Units · Derivative | 202,603 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-025772 · ownership.xml · derivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,603 Underlying: Class A Common Stock · 202,603 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| April 15, 2023 Filed Apr 18, 2023 16:24 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,606 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-013286 · ownership.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,242 Underlying: Class A Common Stock · 2,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. Read SEC document |
| April 15, 2023 Filed Apr 18, 2023 16:24 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 902 | $5.95 | $5,366.90 |
DisclosureSEC source: 0000950170-23-013286 · ownership.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,537 Read SEC document |
| April 15, 2023 Filed Apr 18, 2023 16:24 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-23-013286 · ownership.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 19:57 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 10,201 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-007788 · doc4.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,811 Underlying: Class A Common Stock · 10,201 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% vesting in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 19:57 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 4,160 | $5.50 | $22,880.00 |
DisclosureSEC source: 0000899243-23-007788 · doc4.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,833 Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 19:57 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,201 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-007788 · doc4.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| January 15, 2023 Filed Jan 17, 2023 19:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,606 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-001910 · doc4.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,848 Underlying: Class A Common Stock · 2,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. Read SEC document |
| January 15, 2023 Filed Jan 17, 2023 19:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 1,063 | $5.27 | $5,602.01 |
DisclosureSEC source: 0000899243-23-001910 · doc4.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,792 Read SEC document |
| January 15, 2023 Filed Jan 17, 2023 19:31 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001910 · doc4.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,855 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 17:23 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 10,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-038252 · doc4.xml · derivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,012 Underlying: Class A Common Stock · 10,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% to vest in approximately equal quarterly installments thereafter for 15 quarters. F2 · derivative.expiration_date: The restricted stock unit award vested as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 17:23 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 3,528 | $4.98 | $17,569.44 |
DisclosureSEC source: 0000899243-22-038252 · doc4.xml · nonDerivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,249 Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 17:23 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 10,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-038252 · doc4.xml · nonDerivative · entry 1 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| October 15, 2022 Filed Oct 18, 2022 16:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionRestricted Stock Unit · Derivative | 2,606 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-033739 · doc4.xml · derivative · entry 6 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,454 Underlying: Class A Common Stock · 2,606 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. F2 · derivative.exercise_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. F2 · derivative.expiration_date: The restricted stock units vested 19% on April 15, 2021, and the remaining 81% vested or will vest in equal quarterly installments over the following 15 quarters. Read SEC document |
| October 15, 2022 Filed Oct 18, 2022 16:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Tax withholdingClass A Common Stock | 902 | $4.75 | $4,284.50 |
DisclosureSEC source: 0000899243-22-033739 · doc4.xml · nonDerivative · entry 4 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,577 Read SEC document |
| October 15, 2022 Filed Oct 18, 2022 16:15 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | Exercise / conversionClass A Common Stock | 2,606 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-033739 · doc4.xml · nonDerivative · entry 3 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,479 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Class A common stock. Read SEC document |
| September 22, 2022 Filed Sep 26, 2022 16:47 UTC | GoodRx Holdings, Inc. GDRX · Entity 4838 | GrantRestricted Stock Unit · Derivative | 273,030 | $0.00 Strike: $5.25 | $0.00 |
DisclosureSEC source: 0000899243-22-032044 · doc4.xml · derivative · entry 2 Nabiey Romin · CIK 0001924892 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,212 Underlying: Class A Common Stock · 273,030 shares Expires 2032-09-22 F3 · derivative.exercise_date: The option will vest and become exercisable as to 6.25% of the underlying shares on December 8, 2022 with the remaining 93.75% to vest in approximately equal quarterly installments thereafter for 15 quarters. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.